InsidersTradesSigma
Track the Neurotech International Limited share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, Neurotech International Limited has recorded 2 insider filings. Market capitalisation: €18.5m. The latest transaction was filed on 13 August 2026 (Initial Substantial Holding). Among the most active insiders: Merchant Funds Management Pty Ltd (ABN 32 154 493 277) as manager of the Merchant. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,977 of 28,832 companies
28.3
score / 100
Value5
Quality52
FCF yld-43%
Earn yld-50%
EV/EBITDA·
ROE-66%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 August 2026
Declarations2 total
ShareASXISIN AU000000NTI9ASX:2924-03120853-6A1338460
ShareASXISIN AU000000NTI9ASX:2924-03081944-6A1321790
2 of 2 declarations
About Neurotech International Limited
Neurotech International Limited is a company focused on developing technology-based therapeutic solutions for neurological disorders. It is listed on the XASX market.